Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
2022 Standout
Works of J Rosai being referenced
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| J Rosai | 373 | 82 | 63 | 245 | 176 | 10 | 559 | |
| Xiao‐ge Zhou | 479 | 64 | 13 | 91 | 107 | 13 | 603 | |
| Alejandra Zárate‐Osorno | 254 | 51 | 119 | 42 | 138 | 21 | 528 | |
| Neïla Benameur | 98 | 23 | 122 | 480 | 177 | 12 | 627 | |
| Dariusz Stachurski | 347 | 25 | 36 | 122 | 27 | 14 | 550 | |
| Chin-Yang Li | 138 | 66 | 31 | 54 | 93 | 14 | 569 | |
| ST Yuen | 123 | 162 | 89 | 75 | 49 | 13 | 507 | |
| William D. Wehunt | 185 | 141 | 97 | 70 | 85 | 11 | 553 | |
| Juan Herrada | 326 | 19 | 77 | 147 | 184 | 13 | 642 | |
| L Marelle | 433 | 92 | 15 | 40 | 41 | 9 | 531 | |
| Anne Y. Matsushima | 234 | 86 | 59 | 28 | 45 | 13 | 635 |
All Works
Loading papers...